Shilpa Medicare jumps as investors respond to regulatory approval for key oncology product

Shilpa Medicare jumps as investors respond to regulatory approval for key oncology product

Shilpa Medicare jumps as investors respond to regulatory approval for key oncology product

Shilpa Medicare rose after securing regulatory approval for an oncology product, boosting sentiment on earnings potential and export visibility.






















